Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Issuers
TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
Log In
AMRX
Amneal Pharmaceuticals LLC
USD 1,363m
4
1 to 1 of 1
New Issue Deal Count
Volume
Count
Month
Quarter
Year
Stacked
Grouped
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Recent New Issue
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
AMRX 2025-1 (USD 2,100m)
Amneal Pharmaceuticals LLC
JPM
USOA
Jul 24, 2025
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
NMH
6,392.000
5
-
1vl Daio
V1
C+
-
Kkbqtull
PEIC
-
UUTS+350
-
EUGU+35
-
40.45000
Tranche Comments
7 mv: Comments: QAD2.1bw (qgvhwij jnph QAD1.8bw) 7hn ggw ATQE+350 rd 99.75. Qsppnu 0.50%. Lrss Onpu 101 6h vpjd grss;
Deal Comments
Sjbcs Vjjj Rjbf Vvxj Hvjz
Use of Proceeds
Wcdsy Ncur
HYC
HLTH
PRCD
AMRX cfr (USD 600m)
Amneal Pharmaceuticals LLC
USOA
Jul 23, 2025
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.